Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice.
腸道胰高血糖素樣肽-1:與1型糖尿病小鼠低血糖反應調節失常相關的新角色。
World J Diabetes 2024-08-28
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial.
Liraglutide 增強胰島素分泌並延長新診斷 1 型糖尿病成人的緩解期(NewLira 研究):一項隨機、雙盲、安慰劑對照試驗。
Diabetes Obes Metab 2024-08-28
Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies.
使用 tirzepatide 達成正常血糖:SURPASS J-mono 和 J-combo 研究的事後探索性分析。
Diabetes Obes Metab 2024-08-28
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database.
使用孟德爾隨機化和實際世界藥物監測數據庫對常見藥物與精神疾病之間的關聯進行全面評估。
EBioMedicine 2024-08-27
Regional Heterogeneity of the Results of Glucagon-Like Peptide 1 Receptor Agonist Trials in Type 2 Diabetes: A Reanalysis of Individual Participant Data.
2型糖尿病中胰高血糖素樣肽-1受體激動劑試驗結果的區域異質性:個別參與者數據的再分析。
Diabetes Care 2024-08-27
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-Based Cohort Study.
GLP-1 受體激動劑與 2 型糖尿病患者帕金森病風險:一項基於人群的隊列研究。
Mov Disord 2024-08-27
The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia.
GLP-1 受體激動劑對使用他汀類藥物的糖尿病患者脂質譜的影響:沙烏地阿拉伯 King Salman Bin Abdulaziz 醫院糖尿病中心的回顧性隊列研究。
Cureus 2024-08-27